KRISTEN GORDY: Open Payments
NPI 1811332307 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 29 payments from 10 companies in 2025. Trend: 2023 $274 · 2024 $437 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $161 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, REXULTI, TRINTELLIX, AUSTEDO XR, Auvelity, Qelbree, FANAPT.
Industry payments across MD — which companies pay providers there.
